The narcolepsy-pandemic influenza story: Can the truth ever be unraveled?

Vaccine

Volumn 33, Issue S2, 2015, Pages B6-B13

  Sturkenboom, Miriam C J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Adjuvant; AS03; Awareness bias; Epidemiology; Influenza; Narcolepsy

Indexed keywords

INFLUENZA VACCINE;

DRUG SAFETY; EUROPE; HUMAN; INFLUENZA VACCINATION; NARCOLEPSY; PANDEMIC INFLUENZA; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; CHEMICALLY INDUCED; FINLAND; INFLUENZA, HUMAN; SWEDEN;

EUROPE; FINLAND; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; NARCOLEPSY; SWEDEN;

EID: 84929866913     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.03.026     Document Type: Review

References (42)

1. Ahmed S.S., Schur P.H., MacDonald N.E., Steinman L. Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants. J Autoimmun 2014, 50(May):1-11.
2. Mereckiene J., Cotter S., Weber J., Nicoll A., D'Ancona F., Lopalco P., et al. Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe. Euro Surveill 2012, 17. pii: 20064.
3. European Centre for Disease Prevention and Control Narcolepsy in association with pandemic influenza vaccination (a multi-country European epidemiological investigation) 2012, European Centre for Disease Prevention and Control, Stockholm.
4. Kurz X., Domergue F., Slattery J., Segec A., Szmigiel A., Hidalgo-Simon A. Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance. Vaccine 2011, 29(Jun (26)):4378-4387.
5. Black S., Eskola J., Siegrist C.A., Halsey N., Macdonald N., Law B., et al. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet 2009, 374(Dec (9707)):2115-2122.
6. Dieleman J., Romio S., Johansen K., Weibel D., Bonhoeffer J., Sturkenboom M. Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe. BMJ 2011, 343(Jul):d3908. VAESCO-GBS Case-Control Study Group.
7. Romio S., Weibel D., Dieleman J.P., Olberg H.K., de Vries C.S., Sammon C., et al. Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe. PLoS ONE 2014, 9(1):e82222.
8. Salmon D.A., Proschan M., Forshee R., Gargiullo P., Bleser W., Burwen D.R., et al. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet 2013, 381(Apr (9876)):1461-1468.
9. Dodd C.N., Romio S.A., Black S., Vellozzi C., Andrews N., Sturkenboom M., et al. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine 2013, 31(Sep (40)):4448-4458.
10. Partinen M., Saarenpää-Heikkilä O., Ilveskoski I., Hublin C., Linna M., Olsén P., et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS ONE 2012, 7(3):e33723.
11. European Medicines Agency European medicines agency starts review of Pandemrix 2010 (27 August), Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2010/08/WC500096005.pdf [cited 2012 22/03/2012].
12. Jacob L., Leib R., Ollila H.M., Bonvalet M., Adams C.M., Mignot E. Comparison of Pandemrix and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development. Brain Behav Immun 2014, (Nov).
13. Vaarala O., Vuorela A., Partinen M., Baumann M., Freitag T.L., Meri S., et al. Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for Pandemrix-associated narcolepsy risk. PLoS ONE 2014, 9(12):e114361.
14. Trifirò G., Coloma P.M., Rijnbeek P.R., Romio S., Mosseveld B., Weibel D., et al. Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?. J Intern Med 2014, 275(6):551-561.
15. Nohynek H., Jokinen J., Partinen M., Vaarala O., Kirjavainen T., Sundman J., et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS ONE 2012, 7(3):e33536. Epub 2012 Mar 28. 10.1371/journal.pone.0033536.
16. Medical Products Agency A registry based comparative cohort study in four Swedish counties of the risk for narcolepsy after vaccination with Pandemrix - a first and preliminary report, by the 2011 [March 28] 2011, Available from: www.mpa.se.
17. MPA, Occurrence of narcolepsy with cataplexy among children and adolescents in relation to the H1N1 pandemic and Pandemrix vaccinations - Results of a case inventory study by the MPA in Sweden during 2009-2010. Available from: (accessed March 23, 2015). https://www.lakemedelsverket.se/upload/nyheter/2011/Fallinventeringsrapport_pandermrix_110630.pdf.
18. Persson I., Granath F., Askling J., Ludvigsson J.F., Olsson T., Feltelius N. Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up. J Intern Med 2014, 275(2):172-190.
19. Szakács A., Darin N., Hallböök T. Increased childhood incidence of narcolepsy in western Sweden after H1N1 influenza vaccination. Neurology 2013, 80(14):1315-1321.
20. O'Flanagan D., Barret A., Foley M., Cotter S., Bonner C., Crowe C., et al. Investigation of an association between onset of narcolepsy and vaccination with pandemic influenza vaccine, Ireland April 2009-December 2010. Euro Surveill: bulletin Europeen sur les maladies transmissibles = Eur Commun Dis Bull 2014, 19(17). PubMed PMID:24821121.
21. Heier M.S., Gautvik K.M., Wannag E., Bronder K.H., Midtlyng E., Kamaleri Y., et al. Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A. Sleep Med 2013, 14(9):867-871.
22. Choe Y.J., Bae G.R., Lee D.H. No association between influenza A (H1N1) pdm09 vaccination and narcolepsy in South Korea: an ecological study. Vaccine 2012, 30(52):7439-7442.
23. Duffy J., Weintraub E., Vellozzi C., DeStefano F. Vaccine safety datalink. Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States. Neurology 2014, 83(20):1823-1830.
24. Montplaisir J., Petit D., Quinn M.J., Ouakki M., Deceuninck G., Desautels A., et al. Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec. PLoS ONE 2014, 9(9):e108489.
25. Kornum B., Faraco J., Mignot E. Narcolepsy with hypocretin/orexin deficiency, infections and autoimmunity of the brain. Curr Opin Neurobiol 2011, 21:897-903.
26. Nishino S., Ripley B., Overeem S., Lammers G.J., Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000, 355(Jan (9197)):39-40.
27. Overeem S., Black J.L., Lammers G.J. Narcolepsy: immunological aspects. Sleep Med Rev 2008, 12(Apr (2)):95-107.
28. Luca G., Haba-Rubio J., Dauvilliers Y., Lammers G.J., Overeem S., Donjacour C.E., et al. Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study. J Sleep Res 2013, 22(Oct (5)):482-495.
29. Singh A.K., Mahlios J., Mignot E. Genetic association, seasonal infections and autoimmune basis of narcolepsy. J Autoimmun 2013, 43(Jun):26-31.
30. Longstreth W.T., Koepsell T.D., Ton T.G., Hendrickson A.F., van Belle G. The epidemiology of narcolepsy. Sleep 2007, 30(1):13-26.
31. Poli F., Overeem S., Lammers G.J., Plazzi G., Lecendreux M., Bassetti C.L., et al. Narcolepsy as an adverse event following immunization: case definition and guidelines for data collection, analysis and presentation. Vaccine 2013, 31(Jan (6)):994-1007.
32. Han F., Lin L., Warby S.C., Faraco J., Li J., Dong S.X., et al. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in china. Ann Neurol 2011, 70(3):410-417.
33. Han F., Lin L., Li J., Dong X.S., Mignot E. Decreased incidence of childhood narcolepsy 2 years after the 2009 H1N1 winter flu pandemic. Ann Neurol 2013, 73(4):560.
34. Barker C.I., Snape M.D. Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action. Lancet Infect Dis 2014, 14:227-238.
35. + T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy". Sci Transl Med 2014, 6(Jul (247)):247rt1.
36. Syrjänen R.K., Jokinen J., Ziegler T., Sundman J., Lahdenkari M., Julkunen I., et al. Effectiveness of pandemic and seasonal influenza vaccines in preventing laboratory-confirmed influenza in adults: a clinical cohort study during Epidemic Seasons 2009-2010 and 2010-2011 in Finland. PLoS ONE 2014, 9(9):e108538.
37. Örtqvist A., Berggren I., Insulander M., de Jong B., Svenungsson B. Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v in Stockholm County, Sweden. Clin Infect Dis 2011, 52(10):1203-1211.
38. Melén K., Partinen M., Tynell J., Sillanpää M., Himanen S.-L., Saarenpää-Heikkilä O., Julkunen I., et al. No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood Narcolepsy after Pandemrix vaccination campaign in Finland. PLoS ONE 2013, 8(8):e68402. 10.1371/journal.pone.0068402.
39. Dauvilliers Y., Arnulf I., Lecendreux M., Monaca Charley C, Franco P., Drouot X., et al. Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France. Brain 2013, 136(Aug (Pt 8)):2486-2496. (PubMed PMID:23884811; a journal of neurology).
40. Winstone A.M., Stellitano L., Verity C., Andrews N., Miller E., Stowe J., et al. Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in England. Dev Med Child Neurol 2014, 56(11):1117-1123.
41. Miller E., Andrews N., Stellitano L., Stowe J., Winstone A.M., Shneerson J., et al. Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis. BMJ 2013, 346:f794.
42. Bardage C., Persson I., Ortqvist A., Bergman U., Ludvigsson J.F., Granath F. Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden. BMJ 2011, 343(Oct):d5956.